theMednetRegister

Internal Medicine

Interventional Cardiology   

Questions discussed in this category

Do shorter door-to-balloon (D2B) times impact outcomes in STEMI, if it's already less than 90 minutes, and to what degree (i.e., 30 vs 60 minutes would have a more significant impact)?
1 Answer available
How do you approach revascularization in patients over 75 years with NSTEMI, given recent evidence from the SENIOR-RITA trial that an invasive strategy does not significantly reduce cardiovascular events compared to a conservative strategy?
Kunadian, et al., PMID 39225274
1 Answer available
Do you favor aspirin or P2Y12 inhibitor monotherapy following completion of 12 months of DAPT post-PCI in patients with elevated bleeding risk?
5 Answers available
How have the findings from DanGer Shock RCT changed your perspective on which patients presenting with acute MI complicated by cardiogenic shock would benefit from Impella for additional hemodynamic support?
2 Answers available
What are your top takeaways from ACC 2024?
3 Answers available
What are alternate approaches to medical therapy and/or interventions to consider in patients with refractory, severe coronary vasospasm despite short-acting nitrates, calcium channel blockers, L-arginine, and clonidine?
5 Answers available
What is your approach to counseling a patient with stable but severe multivessel coronary disease if the patient does not wish to undergo bypass surgery? 
And when would you consider referral for staged/complex PCI instead? 
1 Answer available
What is a reasonable hemoglobin goal for patients with chronic anemia presenting with acute MI?
1 Answer available
What is your approach to considering geriatric patients for complex PCI given their overall frailty and increased risk of complications such as bleeding and stroke?
2 Answers available
What are your top takeaways from AHA 2023?
4 Answers available
Should we routinely include geriatric functional assessments to determine candidacy for TAVR?
(ie., assessing gait speed, cognition, physical function, fall history, orthostatic vital signs, etc.)
1 Answer available


Papers discussed in this category

Journal of the American College of Cardiology, 2023 Nov 21
Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
The New England journal of medicine, 2023 Aug 26
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction.
JACC. Cardiovascular interventions, 2014-07
Futility, benefit, and transcatheter aortic valve replacement.
Lancet (London, England), 2015 Jul 15
Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial.
The New England journal of medicine, 2020 Mar 30
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
The New England journal of medicine, 2023 Nov 11
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
Circulation, 2023 Nov 13
Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A 20-Year Study.
Circulation, 2023 Nov 11
Arrhythmic Risk In Biventricular Pacing Compared with Left Bundle Branch Area Pacing: Results From The International LBBAP Collaborative Study (I-CLAS).
Circulation. Cardiovascular quality and outcomes, 2023 Nov 06
Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation in the United States.
American heart journal, 2017 Apr 24
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.
The New England journal of medicine, 2023 Nov 11
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
American heart journal, 2023 Mar 25
Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): Clinical trial rationale and design.
JAMA, 2023 Nov 11
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
American heart journal, 2020 Oct 13
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.
The New England journal of medicine, 2024 Apr 07
Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.
Circulation, 2016-12-13
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
American heart journal, 2022 May 17
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial.
The New England journal of medicine, 2024 Apr 06
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
Circulation, 2019 Nov 17
The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support.
JACC. Heart failure, 2020 Nov
Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality.
The New England journal of medicine, 2013-09-05
Door-to-balloon time and mortality among patients undergoing primary PCI.
The New England journal of medicine, 2024 Sep 01
Invasive Treatment Strategy for Older Patients with Myocardial Infarction.

Related Topics in Internal Medicine

Copyright © 2024 theMednet
All Rights Reserved.